OHR PHARMACEUTICAL INC's ticker is OHRP and the CUSIP is 67778H200. A total of 35 filers reported holding OHR PHARMACEUTICAL INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $37,000 | +164.3% | 19,935 | 0.0% | 0.00% | – |
Q3 2017 | $14,000 | +16.7% | 19,935 | 0.0% | 0.00% | – |
Q2 2017 | $12,000 | -25.0% | 19,935 | 0.0% | 0.00% | – |
Q1 2017 | $16,000 | -44.8% | 19,935 | 0.0% | 0.00% | – |
Q4 2016 | $29,000 | -48.2% | 19,935 | 0.0% | 0.00% | – |
Q3 2016 | $56,000 | -5.1% | 19,935 | -9.1% | 0.00% | – |
Q2 2016 | $59,000 | -84.3% | 21,935 | -81.3% | 0.00% | – |
Q1 2016 | $375,000 | -67.6% | 117,273 | -37.9% | 0.00% | -100.0% |
Q4 2015 | $1,158,000 | +1830.0% | 188,778 | +760.6% | 0.00% | – |
Q3 2015 | $60,000 | -9.1% | 21,935 | -17.5% | 0.00% | – |
Q2 2015 | $66,000 | +10.0% | 26,575 | +10.9% | 0.00% | – |
Q1 2015 | $60,000 | -86.5% | 23,973 | -55.2% | 0.00% | – |
Q4 2014 | $445,000 | +18.0% | 53,548 | +2.7% | 0.00% | – |
Q3 2014 | $377,000 | +1884.2% | 52,133 | +2379.0% | 0.00% | – |
Q2 2014 | $19,000 | -67.8% | 2,103 | -51.8% | 0.00% | – |
Q1 2014 | $59,000 | +436.4% | 4,366 | +191.1% | 0.00% | – |
Q4 2013 | $11,000 | -54.2% | 1,500 | -50.0% | 0.00% | – |
Q3 2013 | $24,000 | – | 3,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GARRISON BRADFORD & ASSOCIATES INC | 93,400 | $258,000 | 0.28% |
Knoll Capital Management, LLC | 205,000 | $566,000 | 0.24% |
Leisure Capital Management | 66,596 | $184,000 | 0.20% |
Hoxton Financial, Inc. | 86,422 | $239,000 | 0.11% |
Cutter & CO Brokerage, Inc. | 53,275 | $147,000 | 0.07% |
Beech Hill Advisors, Inc. | 33,930 | $94,000 | 0.06% |
STONERIDGE INVESTMENT PARTNERS LLC | 127,530 | $352,000 | 0.05% |
Edge Wealth Management LLC | 24,000 | $66,000 | 0.02% |
FineMark National Bank & Trust | 52,589 | $145,000 | 0.02% |
BEACH INVESTMENT COUNSEL INC/PA | 51,872 | $143,000 | 0.02% |